These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7870187)

  • 41. Direct evidence for concomitant release of noradrenaline, adenosine 5'-triphosphate and neuropeptide Y from sympathetic nerve supplying the guinea-pig vas deferens.
    Kasakov L; Ellis J; Kirkpatrick K; Milner P; Burnstock G
    J Auton Nerv Syst; 1988 Feb; 22(1):75-82. PubMed ID: 3351195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens.
    Todorov LD; Mihaylova-Todorova S; Craviso GL; Bjur RA; Westfall DP
    J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):731-48. PubMed ID: 8930840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of calcium-entry modulators on the biphasic neurogenic contractions in the circular muscle of guinea pig vas deferens.
    Suzuki N; Gomi Y
    Jpn J Pharmacol; 1989 Jan; 49(1):59-65. PubMed ID: 2470942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
    Cleary L; Vandeputte C; Docherty JR
    Br J Pharmacol; 2003 Mar; 138(6):1069-76. PubMed ID: 12684262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neocuproine, a copper (I) chelator, potentiates purinergic component of vas deferens contractions elicited by electrical field stimulation.
    Göçmen C; Kumcu EK; Büyüknacar HS; Onder S; Singirik E
    Pharmacology; 2005 Oct; 75(2):69-75. PubMed ID: 16020948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens.
    von Kügelgen I; Schöffel E; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):522-32. PubMed ID: 2559333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study of ATP as a sympathetic cotransmitter in human saphenous vein.
    Rump LC; von Kügelgen I
    Br J Pharmacol; 1994 Jan; 111(1):65-72. PubMed ID: 7912156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of the effects of exogenous and endogenous prostaglandins on fast and slow contractions of field-stimulated guinea-pig vas deferens.
    McKay AM; Poyser NL
    Br J Pharmacol; 1995 Nov; 116(6):2679-84. PubMed ID: 8590989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age-dependent modulation of neuropeptide Y on adrenergic transmission of guinea pig vas deferens.
    Chernaeva L; Yankova M
    Gen Pharmacol; 1991; 22(4):611-6. PubMed ID: 1657685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel dual 'small' vesicle model of ATP- and noradrenaline-mediated sympathetic neuromuscular transmission.
    Stjärne L
    Auton Neurosci; 2001 Feb; 87(1):16-36. PubMed ID: 11270138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig.
    Sneddon P; Machaly M
    J Auton Pharmacol; 1992 Dec; 12(6):421-8. PubMed ID: 1474107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of heptanol on the neurogenic and myogenic contractions of the guinea-pig vas deferens.
    Venkateswarlu K; Dange SY; Manchanda R
    Br J Pharmacol; 1999 Jan; 126(1):227-34. PubMed ID: 10051140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chloroethylclonidine: an irreversible agonist at prejunctional alpha 2-adrenoceptors in rat vas deferens.
    Bültmann R; Starke K
    Br J Pharmacol; 1993 Feb; 108(2):336-41. PubMed ID: 8095416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens.
    Sneddon P; Westfall DP
    J Physiol; 1984 Feb; 347():561-80. PubMed ID: 6142947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The mechanisms of enhancement and inhibition of field stimulation responses of guinea-pig vas deferens by prostacyclin analogues.
    Tam FS; Chan K; Borreau JP; Jones RL
    Br J Pharmacol; 1997 Aug; 121(7):1413-21. PubMed ID: 9257922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin-induced facilitation of sympathetic neurotransmission to the rat vas deferens: effects of suramin.
    Lau WA; Ventura S; Jiang Q; Pennefather JN
    Eur J Pharmacol; 1995 Jan; 272(1):31-8. PubMed ID: 7536159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. P2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens.
    von Kügelgen I; Kurz K; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):125-32. PubMed ID: 7909584
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropeptide Y neuromodulation of sympathetic co-transmission in the guinea-pig vas deferens.
    Ellis JL; Burnstock G
    Br J Pharmacol; 1990 Jul; 100(3):457-62. PubMed ID: 2167733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suramin inhibits excitatory junction potentials in guinea-pig isolated vas deferens.
    Sneddon P
    Br J Pharmacol; 1992 Sep; 107(1):101-3. PubMed ID: 1330153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-I from Brazilian scorpion Tityus serrulatus.
    Conceição IM; Jurkiewicz A; Fonseca DR; Opperman AR; Freitas TA; Lebrun I; Garcez-do-Carmo L
    Br J Pharmacol; 2005 Feb; 144(4):519-27. PubMed ID: 15678093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.